Clinuvel Continues Share Buy-Back Campaign

Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.

Clinuvel Pharmaceuticals Limited has announced an ongoing buy-back of its shares, with the latest update indicating that the company purchased 3,800 shares on the previous day, adding to a total of 61,190 shares bought back to date. This buy-back is part of their market strategy to reacquire ordinary fully paid shares, under the ASX code CUV, as detailed in their latest daily notification.

For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.